应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03378 翰思艾泰-B
未开盘 06-09 16:08:11
26.660
-0.340
-1.26%
最高
27.040
最低
25.140
成交量
15.99万
今开
27.560
昨收
27.000
日振幅
7.04%
总市值
35.99亿
流通市值
35.99亿
总股本
1.35亿
成交额
419.56万
换手率
0.12%
流通股本
1.35亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
翰思艾泰-B(03378.HK)6月9日耗资182.3万港元回购6.88万股
中金财经 · 06-09 19:47
翰思艾泰-B(03378.HK)6月9日耗资182.3万港元回购6.88万股
翰思艾泰-B回购6.88万股股份,总额约182.28万港元
公告速递 · 06-09 19:35
翰思艾泰-B回购6.88万股股份,总额约182.28万港元
翰思艾泰-B:6月8日回购6.24万股,耗资约167.85万港元
公告速递 · 06-08 19:40
翰思艾泰-B:6月8日回购6.24万股,耗资约167.85万港元
翰思艾泰-B(03378)6月8日斥资167.85万港元回购6.24万股
智通财经 · 06-08 19:40
翰思艾泰-B(03378)6月8日斥资167.85万港元回购6.24万股
翰思艾泰-B回购3.91万股股份,耗资约106.49万港元
公告速递 · 06-05
翰思艾泰-B回购3.91万股股份,耗资约106.49万港元
翰思艾泰-B:6月4日回购27,700股,耗资约76.54万港元
公告速递 · 06-04
翰思艾泰-B:6月4日回购27,700股,耗资约76.54万港元
翰思艾泰-B(03378)6月4日斥资76.54万港元回购2.77万股
智通财经 · 06-04
翰思艾泰-B(03378)6月4日斥资76.54万港元回购2.77万股
翰思艾泰-B回购53,100股,耗资约143.51万港元
公告速递 · 06-03
翰思艾泰-B回购53,100股,耗资约143.51万港元
翰思艾泰-B(03378)6月3日耗资约143.51万港元回购5.31万股
智通财经 · 06-03
翰思艾泰-B(03378)6月3日耗资约143.51万港元回购5.31万股
翰思艾泰-B更新5月股份变动月报表,股本总数维持136,218,830股
公告速递 · 06-03
翰思艾泰-B更新5月股份变动月报表,股本总数维持136,218,830股
翰思艾泰-B回购4.02万股股份,总额约106.80万港元
公告速递 · 06-02
翰思艾泰-B回购4.02万股股份,总额约106.80万港元
翰思艾泰-B授予董事会回购授权 规模最高达已发行H股10%
公告速递 · 06-02
翰思艾泰-B授予董事会回购授权 规模最高达已发行H股10%
翰思艾泰-B6月1日回购1.87万股,耗资约51.76万港元
公告速递 · 06-01
翰思艾泰-B6月1日回购1.87万股,耗资约51.76万港元
翰思艾泰-B(03378)6月1日耗资约51.76万港元回购1.87万股
智通财经 · 06-01
翰思艾泰-B(03378)6月1日耗资约51.76万港元回购1.87万股
翰思艾泰-B回购1.82万股股份,总额约47.75万港元
公告速递 · 05-29
翰思艾泰-B回购1.82万股股份,总额约47.75万港元
翰思艾泰-B(03378)5月28日耗资约49.41万港元回购1.81万股
智通财经 · 05-28
翰思艾泰-B(03378)5月28日耗资约49.41万港元回购1.81万股
翰思艾泰-B:5月28日回购1.81万股,涉资约49.41万港元
公告速递 · 05-28
翰思艾泰-B:5月28日回购1.81万股,涉资约49.41万港元
翰思艾泰-B回购22,400股股份,总额约63.12万港元
公告速递 · 05-27
翰思艾泰-B回购22,400股股份,总额约63.12万港元
翰思艾泰-B:5月26日回购24,300股,耗资约69.90万港元
公告速递 · 05-26
翰思艾泰-B:5月26日回购24,300股,耗资约69.90万港元
翰思艾泰-B(03378)5月26日斥资69.9万港元回购2.43万股
智通财经 · 05-26
翰思艾泰-B(03378)5月26日斥资69.9万港元回购2.43万股
加载更多
公司概况
公司名称:
翰思艾泰-B
所属市场:
SEHK
上市日期:
--
主营业务:
翰思艾泰生物医药科技(武汉)股份有限公司是一家主要从事肿瘤免疫疗法的研发的中国公司。该公司的产品管线有针对肿瘤学的临床阶段候选药物和临床前阶段候选药物,包括核心产品HX009及主要产品HX301及HX044,以及针对自身免疫和肿瘤市场的抗体偶联药物、双特异性抗体及单克隆抗体。HX009是一种自主研发的抗程序性细胞死亡蛋白1(PD-1)/信号调节蛋白α(SIRPα)双功能抗体融合蛋白。HX301是一种靶向集落刺激因子-1受体(CSF1R)、AMPK相关蛋白激酶5(ARK5)、FMS样酪氨酸激酶3(FLT-3)及细胞周期蛋白依赖性激酶4/6(CDK4/6)等关键通路的多靶点激酶抑制剂。HX044为一种新型双重功能抗细胞毒性T淋巴细胞相关蛋白4(CTLA-4)抗体SIRPα融合蛋白。
发行价格:
--
{"stockData":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"翰思艾泰-B","latestPrice":26.66,"timestamp":1780992491255,"preClose":27,"halted":0,"volume":159900,"delay":0,"changeRate":-0.012592592592592588,"floatShares":135000000,"shares":135000000,"eps":-1.11,"marketStatus":"未开盘","change":-0.34,"latestTime":"06-09 16:08:11","open":27.56,"high":27.04,"low":25.14,"amount":4195568,"amplitude":0.07037,"askPrice":26.8,"askSize":900,"bidPrice":26.66,"bidSize":900,"shortable":0,"etf":0,"ttmEps":-1.071,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":0,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":27,"openAndCloseTimeList":[[1780968600000,1780977600000],[1780981200000,1780992000000]],"volumeRatio":1.7532894759911706,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000905","market":"SZ","secType":"STK","nameCN":"厦门港务","latestPrice":8.66,"timestamp":1780988400000,"preClose":8.7,"halted":0,"volume":7620800,"delay":0,"premium":"+166.27"}},"requestUrl":"/m/hq/s/03378","defaultTab":"news","newsList":[{"id":"2642462779","title":"翰思艾泰-B(03378.HK)6月9日耗资182.3万港元回购6.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642462779?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:47","pubTimestamp":1781005623,"startTime":"0","endTime":"0","summary":"格隆汇6月9日丨翰思艾泰-B(03378.HK)公告,6月9日耗资182.3万港元回购6.88万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260609/32274669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1535","BK1173","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111680366","title":"翰思艾泰-B回购6.88万股股份,总额约182.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111680366","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111680366?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:35","pubTimestamp":1781004948,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月9日公告称,公司当日在香港联交所以每股25.72港元至27.56港元的价格区间回购普通H股68,800股,占回购前已发行股本约0.051%,涉及金额共1,822,848港元,折合约182.28万港元。公司此前于2026年2月12日通过了股份回购授权,授权可回购的股份总数为13,621,883股,截至目前已回购1,176,000股。公司确认已遵守相关上市规则与适用法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购6.88万股股份,总额约182.28万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143479336","title":"翰思艾泰-B:6月8日回购6.24万股,耗资约167.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143479336","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143479336?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:40","pubTimestamp":1780918855,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月8日公告,已在香港联交所场内回购6.24万股普通股。该回购股份约占公司已发行股本0.046%,每股价格介乎港币25.94元至28元,总金额为1,678,514港元。此次回购基于2026年2月12日通过的购回授权进行,授权可回购股份总数为13,621,883股,公司目前已回购1,107,200股,约占授权通过当日公司已发行股本的0.8128%。公司确认,此次回购符合香港联交所上市规则及相关法律要求。公告由董事长兼执行董事张发明签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B:6月8日回购6.24万股,耗资约167.85万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489757","title":"翰思艾泰-B(03378)6月8日斥资167.85万港元回购6.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489757","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641489757?lang=zh_cn&edition=full","pubTime":"2026-06-08 19:40","pubTimestamp":1780918851,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)发布公告,于2026年6月8日,该公司斥资167.85万港元回购6.24万股股份,每股回购价25.94-28港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","03378","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123090930","title":"翰思艾泰-B回购3.91万股股份,耗资约106.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1123090930","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123090930?lang=zh_cn&edition=full","pubTime":"2026-06-05 18:56","pubTimestamp":1780656985,"startTime":"0","endTime":"0","summary":"2026年6月5日,翰思艾泰生物医药科技(武汉)股份有限公司发布公告,披露了当日于香港联合交易所回购股份的相关信息。公司于2026年6月5日回购普通股H股3.91万股,约占回购前已发行股份总数的0.029%。本次回购的每股价格介于26.52港元至27.98港元之间,合计支付对价1,064,884港元,折合约106.49万港元。公告显示,截至回购完成后,公司已发行股份数量从135,213,130股降至135,174,030股,库藏股数量则由1,005,700股增加至1,044,800股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购3.91万股股份,耗资约106.49万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119166400","title":"翰思艾泰-B:6月4日回购27,700股,耗资约76.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119166400","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119166400?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:11","pubTimestamp":1780575093,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月4日发布公告,披露在香港联交所场内回购27,700股H股普通股,约占该公司已发行股份总数的0.02%。每股回购价格介乎每股港币27.20元至28.00元,合计付出约76.54万港元。经此次回购后,翰思艾泰-B已发行股本合计136,218,830股,其中135,213,130股为已发行流通股,1,005,700股为库存股份。公告同时显示,该公司在本次回购实施后30天内不进行任何新股发行或库存股份再出售或转让,暂定至2026年7月4日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"翰思艾泰-B:6月4日回购27,700股,耗资约76.54万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640015785","title":"翰思艾泰-B(03378)6月4日斥资76.54万港元回购2.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640015785","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640015785?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:11","pubTimestamp":1780575081,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)发布公告,于2026年6月4日斥资76.54万港元回购2.77万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1535","BK1173","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131039557","title":"翰思艾泰-B回购53,100股,耗资约143.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131039557","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131039557?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:35","pubTimestamp":1780486547,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月3日发布翌日报表公告,披露了本公司在香港联交所场内进行的股份回购及已发行股本变动情况。本次回购于2026年6月3日完成,共回购53,100股H股普通股,占回购前公司135,293,930股已发行股份约0.039%,最高回购价每股27.66港元,最低回购价每股26.00港元,合计付出约143.51万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购53,100股,耗资约143.51万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640091289","title":"翰思艾泰-B(03378)6月3日耗资约143.51万港元回购5.31万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640091289","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640091289?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:33","pubTimestamp":1780486419,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)公布,2026年6月3日耗资约143.51万港元回购5.31万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","BK1161","03378","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128554706","title":"翰思艾泰-B更新5月股份变动月报表,股本总数维持136,218,830股","url":"https://stock-news.laohu8.com/highlight/detail?id=1128554706","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128554706?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:02","pubTimestamp":1780480956,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月3日发布截至2026年5月31日的股份变动月报表。报告显示,公司本月股本总数与上月底相同,仍为136,218,830股,其中法定/注册资本的概念不适用,仅指公司已发行股本。公告中确认,公司继续符合香港联交所相关上市规则所要求的最低公众持股量规定。公司表示,将持续严格遵守香港联交所《上市规则》及有关法规的要求,依法合规开展股份管理相关工作。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154114042","title":"翰思艾泰-B回购4.02万股股份,总额约106.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154114042","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154114042?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:41","pubTimestamp":1780400485,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月2日披露翌日披露报表,宣布于同日通过香港联交所场内回购股份。该公司回购共计40,200股H股,占当日公司现有已发行股份的约0.03%,回购价格区间为每股25.34港元至28.42港元,总金额约106.80万港元。本次回购完成后,公司持有的库存股份增加至924,900股,公司已发行股份变动后剩余135,293,930股,合计已发行股份总数136,218,830股。根据公告,相关购回授权于2026年2月12日获股东大会通过,可回购总数为13,621,883股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购4.02万股股份,总额约106.80万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114323583","title":"翰思艾泰-B授予董事会回购授权 规模最高达已发行H股10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114323583","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114323583?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:41","pubTimestamp":1780393307,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司近日在港交所披露通告,拟于股东周年大会上授予董事会回购股份的一般授权,回购规模上限为待决议通过当日已发行H股总数10%。据了解,该公司现有已发行H股合计约1.36亿股,其中约86.6万股为库存股份。董事会认为,该回购举措有助于优化股权结构,维护公司及股东整体利益。翰思艾泰-B董事会强调,预计本次回购不会对公司正常经营和财务稳健造成重大影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"翰思艾泰-B授予董事会回购授权 规模最高达已发行H股10%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126453100","title":"翰思艾泰-B6月1日回购1.87万股,耗资约51.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126453100","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126453100?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:36","pubTimestamp":1780317391,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年6月1日发布翌日披露报表,公告公司于当日回购H股股份并披露最新已发行股本及库存股变动情况。公告显示,2026年6月1日,公司在香港联交所回购普通股H股18,700股,占回购前已发行股份约0.014%,回购最高价为每股港币29.2元,最低价为港币26.6元,总计耗资约51.76万港元。公司于2026年2月12日通过的回购授权显示,许可回购股份总数为13,621,883股,截至目前已合计回购884,700股,占该授权总数约0.6495%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B6月1日回购1.87万股,耗资约51.76万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951767","title":"翰思艾泰-B(03378)6月1日耗资约51.76万港元回购1.87万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951767","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640951767?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:34","pubTimestamp":1780317292,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)公布,2026年6月1日耗资约51.76万港元回购1.87万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1173","03378","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106607628","title":"翰思艾泰-B回购1.82万股股份,总额约47.75万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106607628","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106607628?lang=zh_cn&edition=full","pubTime":"2026-05-29 19:55","pubTimestamp":1780055755,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年5月29日发布翌日披露报表,宣布于香港联交所场内回购18,200股H股普通股,占该次回购前已发行股本约0.013%。本次回购价格区间为每股25.60港元至28.58港元,成交量加权平均价约26.24港元,合计涉资约47.75万港元。回购完成后,公司已发行股份数由135,371,030股降至135,352,830股,库藏股数由847,800股增至866,000股。公司并确认,此次回购已遵守香港联交所上市规则及相关法规,后续新股发行或再出售库藏股将暂缓至2026年6月28日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购1.82万股股份,总额约47.75万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638841693","title":"翰思艾泰-B(03378)5月28日耗资约49.41万港元回购1.81万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638841693","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638841693?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:16","pubTimestamp":1779970601,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)公布,2026年5月28日耗资约49.41万港元回购1.81万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1535","BK1161","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113420320","title":"翰思艾泰-B:5月28日回购1.81万股,涉资约49.41万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113420320","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113420320?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:15","pubTimestamp":1779970552,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年5月28日公告进行了股份回购。该公司于香港联交所场内回购18,100股H股,占当日前公司已发行股本约0.013%。本次回购的价格区间为每股26.50港元至28.50港元,合计支出约49.41万港元。本次回购完成后,公司已发行股份总数保持136,218,830股,其中不含库藏股的已发行股份数为135,371,030股,库藏股数量增至847,800股。公司同时确认,已严格遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B:5月28日回购1.81万股,涉资约49.41万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191402329","title":"翰思艾泰-B回购22,400股股份,总额约63.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191402329","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191402329?lang=zh_cn&edition=full","pubTime":"2026-05-27 18:56","pubTimestamp":1779879369,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年5月27日发布公告称,当日以每股27.52港元至29.48港元的价格区间,回购普通股合计22,400股,约占该次交易前已发行股份的0.017%,合计耗资约63.12万港元。回购完成后,公司已发行股份数目为135,389,130股,库存股份数增至829,700股,总股份数维持136,218,830股。购回授权的决议于2026年2月12日获通过,可根据该授权回购股份总数为13,621,883股。公告数据显示,截至目前,公司已回购合计829,700股,占购回授权通过当日已发行股份数的约0.6091%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B回购22,400股股份,总额约63.12万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133538522","title":"翰思艾泰-B:5月26日回购24,300股,耗资约69.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133538522","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133538522?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:53","pubTimestamp":1779796397,"startTime":"0","endTime":"0","summary":"翰思艾泰生物医药科技(武汉)股份有限公司于2026年5月26日公告,公司当日在香港联交所场内回购H股24,300股,约占该回购前已发行股本的0.018%。此次回购的最高价格为每股30.00港元,最低价格为27.98港元,成交量加权平均价格为28.7646港元,合计动用资金约69.90万港元。公司此前于2026年2月12日获股东大会通过购回授权,授权购回总数为13,621,883股,截至本次回购后已购回807,300股,占获授权当日已发行股本约0.5926%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B:5月26日回购24,300股,耗资约69.90万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638980511","title":"翰思艾泰-B(03378)5月26日斥资69.9万港元回购2.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638980511","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638980511?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:47","pubTimestamp":1779796063,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B(03378)发布公告,于2026年5月26日斥资69.9万港元回购2.43万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰思艾泰-B(03378)5月26日斥资69.9万港元回购2.43万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03378","BK1173","BK1535","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hanxbio.com/","stockEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.172},{"period":"3month","weight":0.4032},{"period":"6month","weight":-0.1669},{"period":"ytd","weight":0.6683}],"compareEarnings":[{"period":"1week","weight":-0.0565},{"period":"1month","weight":-0.0693},{"period":"3month","weight":-0.0515},{"period":"6month","weight":-0.0378},{"period":"1year","weight":0.0159},{"period":"ytd","weight":-0.0415}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰思艾泰生物医药科技(武汉)股份有限公司是一家主要从事肿瘤免疫疗法的研发的中国公司。该公司的产品管线有针对肿瘤学的临床阶段候选药物和临床前阶段候选药物,包括核心产品HX009及主要产品HX301及HX044,以及针对自身免疫和肿瘤市场的抗体偶联药物、双特异性抗体及单克隆抗体。HX009是一种自主研发的抗程序性细胞死亡蛋白1(PD-1)/信号调节蛋白α(SIRPα)双功能抗体融合蛋白。HX301是一种靶向集落刺激因子-1受体(CSF1R)、AMPK相关蛋白激酶5(ARK5)、FMS样酪氨酸激酶3(FLT-3)及细胞周期蛋白依赖性激酶4/6(CDK4/6)等关键通路的多靶点激酶抑制剂。HX044为一种新型双重功能抗细胞毒性T淋巴细胞相关蛋白4(CTLA-4)抗体SIRPα融合蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.005427},{"month":2,"riseRate":0.411765,"avgChangeRate":0.008835},{"month":3,"riseRate":0.352941,"avgChangeRate":-0.021319},{"month":4,"riseRate":0.705882,"avgChangeRate":0.100651},{"month":5,"riseRate":0.352941,"avgChangeRate":0.046508},{"month":6,"riseRate":0.470588,"avgChangeRate":-0.00883},{"month":7,"riseRate":0.470588,"avgChangeRate":0.004276},{"month":8,"riseRate":0.470588,"avgChangeRate":-0.031033},{"month":9,"riseRate":0.588235,"avgChangeRate":-0.013577},{"month":10,"riseRate":0.75,"avgChangeRate":0.019136},{"month":11,"riseRate":0.625,"avgChangeRate":0.009468},{"month":12,"riseRate":0.625,"avgChangeRate":0.056179}],"exchange":"SEHK","name":"翰思艾泰-B","nameEN":"HANXBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰思艾泰-B,03378,翰思艾泰-B股票,翰思艾泰-B股票老虎,翰思艾泰-B股票老虎国际,翰思艾泰-B行情,翰思艾泰-B股票行情,翰思艾泰-B股价,翰思艾泰-B股市,翰思艾泰-B股票价格,翰思艾泰-B股票交易,翰思艾泰-B股票购买,翰思艾泰-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰思艾泰-B(03378)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰思艾泰-B(03378)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}